Back
to sessions
Sep 27
Scientific
MODERATOR(S)
Niema Razavian, MD - Moffitt Cancer Center
Sharon Spencer, MD - University of Alabama at Birmingham
Credits
| AMA PRA Category 1 Credits: | 1.00 |
| CAMPEP Credits: | 1.00 |
| MDCB Credits: | 1.00 |
Presentations
-
03:00pm - 03:10pm ET
Pooled Analysis of Prospective Trials of FMISO PET-Guided 30Gy De-Escalation in HPV-Positive Oropharyngeal Cancer
Speaker: Nancy Lee, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York -
03:00pm - 04:00pm ETSpeaker: Niema Razavian, MD - Moffitt Cancer Center, Tampa
-
03:00pm - 04:00pm ETSpeaker: Sharon Spencer, MD - University of Alabama at Birmingham, Birmingham
-
03:10pm - 03:20pm ET
HYpofractionated, Dose-redistributed RAdiotherapy (HYDRA) with Protons or Photons vs. Standard of Care for Head and Neck Squamous Cell Carcinoma: A Randomized Trial
Speaker: Jos Elbers, MD, PhD - Erasmus Medical Center, Rotterdam -
03:20pm - 03:30pm ET
TRINITY-HPV: Transoral RobotIc surgery (TORS) Followed by deinteNsified Post-OperatIve ChemoradioTherapY (CRT) in HPV-Associated Oropharyngeal Carcinoma (OPC)
Speaker: Zachary Zumsteg, MD - Cedars-Sinai Medical Center, Los Angeles -
03:30pm - 03:40pm ET
Oncologic Outcomes of a Multicenter Prospective Study Evaluating ctHPVDNA-Adapted Adjuvant Radiotherapy in Patients with HPV-Associated Oropharyngeal Cancer
Speaker: James Bates, MD - University of North Carolina, Chapel Hill -
03:40pm - 03:50pm ET
Ten-Year Outcomes of Elective Upper-Neck vs. Whole-Neck Irradiation for the Uninvolved Neck in Nasopharyngeal Carcinoma Patients with N0-1 or Unilateral N3 Disease and High Pretreatment Plasma Epstein-Barr Virus DNA Load
Speaker: Wei-Hong Zheng, MD, PhD - Sun Yat-Sen University Cancer Center, Guang Dong Province -
03:50pm - 04:00pm ETSpeaker: C Jillian Tsai, MD, PhD, MS - Princess Margaret Cancer Centre, Toronto